Changes in the levels of neurotrophins such as BDNF are the basis of the neurotrophin hypothesis of depression, which posits that stress and depression lead to impaired neuroplasticity, and that antidepressive treatments increase neuroplasticity. This evidence concerns the gene BDNF and depressive symptom measurement.